Literature DB >> 680595

Role of neural influences in the release of gastrin, glucagon, and secretin during hypoglycaemia in man.

J C McLoughlin, J R Hayes, K D Buchanan, J G Kelly.   

Abstract

Both vagal and sympathetic innervation been have described as influencing hormone release from the gastrointestinal tract and pancreas. The role of neural influences on the release of gastrin, glucagon, and secretin has been studied using the potent autonomic nerve stimulus of hypoglycaemia. Healthy subjects were each rendered hypoglycaemic by insulin 0.2 units/kg on three occasions: after atropine 20 microgram/kg: after propranolol 160 mg orally, and without prior drug administration. Adequate beta-blockade was confirmed by observation of the pusle rate response to a standard exercise at the end of the experiment, and by measurements of plasma propranolol levels. Hypoglycaemia failed to produce a rise in plasma gastrin under either propranolol or control conditions but a significant rise was noted with prior atropinisation. The glucagon response to hypoglycaemia, when measured with either the C- or N-terminal reactive antibodies, was found not to be influenced to any significant extent by either beta-blockade or atropinisation. No alteration in plasma secretin levels was noted during hypoglycaemia. It therefore appears that neural influences are relatively unimportant in the release of gastrin, glucagon, and secretin in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 680595      PMCID: PMC1412078          DOI: 10.1136/gut.19.7.632

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  Studies on adrenaline and noradrenaline in human plasma.

Authors:  A VENDSALU
Journal:  Acta Physiol Scand Suppl       Date:  1960

2.  Comparison of propranolol, metoprolol, and acebutolol on insulin-induced hypoglycaemia.

Authors:  R J Newman
Journal:  Br Med J       Date:  1976-08-21

3.  Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia.

Authors:  E A Abramson; R A Arky; K A Woeber
Journal:  Lancet       Date:  1966-12-24       Impact factor: 79.321

4.  Receptor mechanisms in the hyperglycaemic response to adrenaline in man.

Authors:  A Antonis; M L Clark; R L Hodge; M Molony; T R Pilkington
Journal:  Lancet       Date:  1967-05-27       Impact factor: 79.321

5.  Stimulation of gastrin release by catecholamines.

Authors:  J R Hayes; T L Kennedy; J Ardill; R G Shanks; K D Buchanan
Journal:  Lancet       Date:  1972-04-15       Impact factor: 79.321

6.  Radioimmunological determination of pancreatic and gut glucagon in plasma.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1971-02       Impact factor: 10.122

7.  The use of drug concentration measurements in studies of the therapeutic response to propranolol.

Authors:  C Chidsey; M Pine; L Favrot; S Smith; G Leonetti; P Morselli; A Zanchetti
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

8.  The role of the autonomic innervation in the control of glucagon release during hypoglycaemia in the calf.

Authors:  S R Bloom; A V Edwards; N J Vaughan
Journal:  J Physiol       Date:  1974-02       Impact factor: 5.182

9.  The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf.

Authors:  S R Bloom; A V Edwards; N J Vaughan
Journal:  J Physiol       Date:  1973-09       Impact factor: 5.182

10.  Vagal control of glucagon release in man.

Authors:  S R Bloom; N J Vaughan; R C Russell
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

View more
  2 in total

1.  Effects of physiological increases of plasma noradrenaline on gastric acid secretion and gastrointestinal hormones.

Authors:  H Graffner; S R Bloom; L O Farnebo; J Järhult
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

2.  Insulin and myoelectric activity of the small intestine of the pig.

Authors:  V Rayner; T E Weekes; J B Bruce
Journal:  Dig Dis Sci       Date:  1981-01       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.